LF
LEGN icon

Lansforsakringar Fondforvaltning’s Legend Biotech LEGN Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$271K Hold
15,000
– – ﹤0.01% 548
2025
Q4 		$326K Buy
15,000
+3,000
+25% +$85.9K ﹤0.01% 539
2025
Q3 		$391K Hold
12,000
– – ﹤0.01% 526
2025
Q2 		$426K Sell
12,000
-15,810
-57% -$512K ﹤0.01% 526
2025
Q1 		$944K Sell
27,810
-283
-1% -$10.1K 0.01% 519
2024
Q4 		$914K Buy
+28,093
New +$1.16M 0.01% 520

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Lansforsakringar Fondforvaltning's LEGN Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning held its Legend Biotech (LEGN) position steady in Q1 2026 at 15,000 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #548.

Lansforsakringar Fondforvaltning first reported a position in LEGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $944K in Q1 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Lansforsakringar Fondforvaltning held 15,000 shares of Legend Biotech worth $271K as of Q1 2026.
  • Lansforsakringar Fondforvaltning left its Legend Biotech share count unchanged in Q1 2026.
  • Legend Biotech made up ﹤0.01% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #548 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Legend Biotech in Q4 2024 and has held it in 6 quarters since.
  • Lansforsakringar Fondforvaltning's Legend Biotech position peaked at $944K in Q1 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.